Business Description
Cliniphar Ltd
ISIN : JP3270300001
Total Employee Number:
27Compare
Compare
Traded in other countries / regions
432A.Japan IPO Date
2025-10-07Description
Cliniphar Ltd is engaged in Pharmaceutical Wholesale and Distribution Business for Domestic and International Markets.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.39 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.83 | |||||
Debt-to-EBITDA | 5.55 | |||||
Interest Coverage | 16.67 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.4 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.15 | |||||
Quick Ratio | 1.83 | |||||
Cash Ratio | 1.6 | |||||
Days Inventory | 34.54 | |||||
Days Sales Outstanding | 12.63 | |||||
Days Payable | 2.1 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 17.38 | |||||
Operating Margin % | 3.63 | |||||
Net Margin % | 4.35 | |||||
EBITDA Margin % | 5.04 | |||||
FCF Margin % | 7.25 | |||||
OCF Margin % | 7.54 | |||||
ROE % | 14.25 | |||||
ROA % | 6.12 | |||||
ROIC % | 8.51 | |||||
ROC (Joel Greenblatt) % | 43.93 | |||||
ROCE % | 8.2 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 9.01 | |||||
PE Ratio without NRI | 8.5 | |||||
PS Ratio | 0.39 | |||||
PB Ratio | 1.17 | |||||
Price-to-Tangible-Book | 1.23 | |||||
Price-to-Free-Cash-Flow | 5.4 | |||||
Price-to-Operating-Cash-Flow | 5.2 | |||||
EV-to-EBIT | 11.17 | |||||
EV-to-EBITDA | 9.24 | |||||
EV-to-Revenue | 0.47 | |||||
EV-to-FCF | 6.43 | |||||
Price-to-Graham-Number | 0.68 | |||||
| Price-to-Net-Current-Asset-Value | 2.51 | |||||
| Price-to-Net-Cash | 17.29 | |||||
Earnings Yield (Greenblatt) % | 8.95 | |||||
FCF Yield % | 18.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cliniphar Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 3,700.714 | ||
| EPS (TTM) (円) | 161.012 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (円) | - | ||
| 20-Day SMA (円) | 1450 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (円) | 1450 - 1450 | ||
| Shares Outstanding (Mil) | 1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cliniphar Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cliniphar Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cliniphar Ltd Frequently Asked Questions
What is Cliniphar Ltd(TSE:432A)'s stock price today?
The current price of TSE:432A is 円1450.00. The 52 week high of TSE:432A is 円1450.00 and 52 week low is 円1450.00.
When is next earnings date of Cliniphar Ltd(TSE:432A)?
The next earnings date of Cliniphar Ltd(TSE:432A) is .
Does Cliniphar Ltd(TSE:432A) pay dividends? If so, how much?
Cliniphar Ltd(TSE:432A) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Cliniphar Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers